- Home
- MAIA vs IROQ Comparison
MAIA vs IROQ Comparison
Compare MAIA & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- IROQ
- Stock Information
- Founded
- MAIA 2018
- IROQ 1883
- Country
- MAIA United States
- IROQ United States
- Employees
- MAIA N/A
- IROQ N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- IROQ Savings Institutions
- Sector
- MAIA Health Care
- IROQ Finance
- Exchange
- MAIA Nasdaq
- IROQ Nasdaq
- Market Cap
- MAIA 52.7M
- IROQ 60.4M
- IPO Year
- MAIA 2022
- IROQ 2011
- Fundamental
- Price
- MAIA $2.00
- IROQ $22.82
- Analyst Decision
- MAIA
- IROQ
- Analyst Count
- MAIA 0
- IROQ 0
- Target Price
- MAIA N/A
- IROQ N/A
- AVG Volume (30 Days)
- MAIA 233.1K
- IROQ 2.7K
- Earning Date
- MAIA 11-12-2024
- IROQ 01-28-2025
- Dividend Yield
- MAIA N/A
- IROQ 1.75%
- EPS Growth
- MAIA N/A
- IROQ N/A
- EPS
- MAIA N/A
- IROQ 0.62
- Revenue
- MAIA N/A
- IROQ $22,441,000.00
- Revenue This Year
- MAIA N/A
- IROQ N/A
- Revenue Next Year
- MAIA N/A
- IROQ N/A
- P/E Ratio
- MAIA N/A
- IROQ $36.56
- Revenue Growth
- MAIA N/A
- IROQ N/A
- 52 Week Low
- MAIA $0.95
- IROQ $14.85
- 52 Week High
- MAIA $5.99
- IROQ $24.00
- Technical
- Relative Strength Index (RSI)
- MAIA 40.60
- IROQ 53.77
- Support Level
- MAIA $1.93
- IROQ $22.61
- Resistance Level
- MAIA $2.63
- IROQ $23.40
- Average True Range (ATR)
- MAIA 0.21
- IROQ 0.55
- MACD
- MAIA 0.02
- IROQ -0.08
- Stochastic Oscillator
- MAIA 21.22
- IROQ 47.56
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others, and also a variety of deposit accounts and alternative delivery channels.